Advances in multidisciplinary and cross-species approaches to examine the neurobiology of psychiatric disorders.
Current approaches to dissect the molecular neurobiology of complex neuropsychiatric disorders such as schizophrenia and major depression have been rightly criticized for failing to provide benefits to patients. Improving the translational potential of our efforts will require the development and refinement of better disease models that consider a wide variety of contributing factors, such as genetic variation, gene-by-environment interactions, endophenotype or intermediate phenotype assessment, cross species analysis, sex differences, and developmental stages. During a targeted expert meeting of the European College of Neuropsychopharmacology (ECNP) in Istanbul, we addressed the opportunities and pitfalls of current translational animal models of psychiatric disorders and agreed on a series of core guidelines and recommendations that we believe will help guiding further research in this area.
Department of Neuroscience and Pharmacology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, The Netherlands. m.j.h.kas@umcutrecht.nl
Martien J H
MJ
Kas
Vaishnav
V
Krishnan
Todd D
TD
Gould
David A
DA
Collier
Berend
B
Olivier
Klaus-Peter
KP
Lesch
Enrico
E
Domenici
Eberhard
E
Fuchs
Cornelius
C
Gross
Eero
E
Castrén
D000375:Aging; D058068:Endophenotypes; D005260:Female; D006801:Humans; D033183:Interdisciplinary Communication; D008297:Male; D001523:Mental Disorders / Q000235:genetics* / Q000503:physiopathology*; D009446:Neurobiology; D058027:Neuropsychiatry; D012737:Sex Factors; D013045:Species Specificity